JPH11514217A - 結核の診断のための化合物および方法 - Google Patents

結核の診断のための化合物および方法

Info

Publication number
JPH11514217A
JPH11514217A JP9511465A JP51146597A JPH11514217A JP H11514217 A JPH11514217 A JP H11514217A JP 9511465 A JP9511465 A JP 9511465A JP 51146597 A JP51146597 A JP 51146597A JP H11514217 A JPH11514217 A JP H11514217A
Authority
JP
Japan
Prior art keywords
seq
polypeptide
detecting
antigen
tuberculosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP9511465A
Other languages
English (en)
Japanese (ja)
Other versions
JPH11514217A5 (enExample
Inventor
ジー． リード，スティーブン
エイ．ダブリュー． スキーキー，イェイサー
シー． ディロン，デイヴィン
カンポス−ネト，アントニオ
ホートン，レイモンド
エイチ． ヴェドヴィック，トーマス
アール． トワードズィック，ダニエル
Original Assignee
コリクサ コーポレイション
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27541833&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JPH11514217(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by コリクサ コーポレイション filed Critical コリクサ コーポレイション
Publication of JPH11514217A publication Critical patent/JPH11514217A/ja
Publication of JPH11514217A5 publication Critical patent/JPH11514217A5/ja
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/5695—Mycobacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Zoology (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
JP9511465A 1995-09-01 1996-08-30 結核の診断のための化合物および方法 Ceased JPH11514217A (ja)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US52343595A 1995-09-01 1995-09-01
US53213695A 1995-09-22 1995-09-22
US62028096A 1996-03-22 1996-03-22
US65880096A 1996-06-05 1996-06-05
US68057396A 1996-07-12 1996-07-12
US08/658,800 1996-07-12
US08/532,136 1996-07-12
US08/523,435 1996-07-12
US08/680,573 1996-07-12
US08/620,280 1996-07-12
PCT/US1996/014675 WO1997009429A2 (en) 1995-09-01 1996-08-30 Compounds and methods for diagnosis of tuberculosis

Publications (2)

Publication Number Publication Date
JPH11514217A true JPH11514217A (ja) 1999-12-07
JPH11514217A5 JPH11514217A5 (enExample) 2004-09-16

Family

ID=27541833

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9511465A Ceased JPH11514217A (ja) 1995-09-01 1996-08-30 結核の診断のための化合物および方法

Country Status (13)

Country Link
EP (2) EP0850305B1 (enExample)
JP (1) JPH11514217A (enExample)
CN (2) CN1154730C (enExample)
AT (2) ATE324445T1 (enExample)
AU (1) AU7158796A (enExample)
CA (1) CA2230927A1 (enExample)
CY (1) CY2618B2 (enExample)
DE (1) DE69636075D1 (enExample)
DK (1) DK2154248T3 (enExample)
ES (1) ES2378051T3 (enExample)
MX (1) MX9801687A (enExample)
PT (1) PT2154248E (enExample)
WO (1) WO1997009429A2 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009084481A1 (ja) * 2007-12-28 2009-07-09 Bl Co., Ltd. 結核菌群の免疫検出法

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6641814B1 (en) 1997-04-02 2003-11-04 Statens Serum Institut Nucleic acids fragments and polypeptide fragments derived from M. tuberculosis
US6991797B2 (en) 1993-07-02 2006-01-31 Statens Serum Institut M. tuberculosis antigens
US6458366B1 (en) 1995-09-01 2002-10-01 Corixa Corporation Compounds and methods for diagnosis of tuberculosis
US6592877B1 (en) 1995-09-01 2003-07-15 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
US6290969B1 (en) 1995-09-01 2001-09-18 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
CA2268036A1 (en) * 1996-10-11 1998-04-23 Corixa Corporation Compounds and methods for diagnosis of tuberculosis
US6544522B1 (en) * 1998-12-30 2003-04-08 Corixa Corporation Fusion proteins of mycobacterium tuberculosis antigens and their uses
US6350456B1 (en) 1997-03-13 2002-02-26 Corixa Corporation Compositions and methods for the prevention and treatment of M. tuberculosis infection
US6627198B2 (en) 1997-03-13 2003-09-30 Corixa Corporation Fusion proteins of Mycobacterium tuberculosis antigens and their uses
JP4172598B2 (ja) * 1997-04-02 2008-10-29 スタテンス セールム インスティトゥート 結核菌由来の核酸フラグメント及びポリペプチドフラグメント
US6982085B2 (en) 1997-04-02 2006-01-03 Statens Serum Institut TB diagnostic based on antigens from M. tuberculosis
US7037510B2 (en) 1997-04-18 2006-05-02 Statens Serum Institut Hybrids of M. tuberculosis antigens
US6555653B2 (en) * 1997-05-20 2003-04-29 Corixa Corporation Compounds for diagnosis of tuberculosis and methods for their use
US6613881B1 (en) * 1997-05-20 2003-09-02 Corixa Corporation Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use
WO1999004005A1 (en) * 1997-07-16 1999-01-28 Institut Pasteur A polynucleotide functionally coding for the lhp protein from mycobacterium tuberculosis, its biologically active derivative fragments, as well as methods using the same
WO1999024577A1 (en) * 1997-11-10 1999-05-20 Statens Serum Institut NUCLEIC ACID FRAGMENTS AND POLYPEPTIDE FRAGMENTS DERIVED FROM $i(M. TUBERCULOSIS)
EP1484405A1 (en) * 1997-11-10 2004-12-08 Statens Serum Institut Nucleic acid fragments and polypeptide fragments derived from M. Tuberculosis
EP0921397A1 (en) * 1997-12-08 1999-06-09 Kreatech Biotechnology B.V. A method for identifying a mycobacterium species
BR9909472A (pt) 1998-04-07 2001-09-11 Corixa Corp Polipeptìdeo purificado, processo para prevenir tuberculose, e, composição farmacêutica
US6183957B1 (en) * 1998-04-16 2001-02-06 Institut Pasteur Method for isolating a polynucleotide of interest from the genome of a mycobacterium using a BAC-based DNA library application to the detection of mycobacteria
GB9808720D0 (en) * 1998-04-23 1998-06-24 Smithkline Beecham Biolog Novel compounds
CA2340085A1 (en) * 1998-08-10 2000-02-24 Chiron Corporation Engineered antigen-presenting cells expressing an array of antigens and uses thereof
US6465633B1 (en) 1998-12-24 2002-10-15 Corixa Corporation Compositions and methods of their use in the treatment, prevention and diagnosis of tuberculosis
WO2000066157A1 (en) 1999-05-04 2000-11-09 The Public Health Research Institute Of The City Of New York, Inc. Proteins expressed by mycobacterium tuberculosis and not by bcg and their use as diagnostic reagents and vaccines
EP1517913B9 (en) * 1999-10-07 2007-08-29 Corixa Corporation A mycobacterium tuberculosis coding sequence for exression of heterologous proteins
US7009042B1 (en) 1999-10-07 2006-03-07 Corixa Corporation Methods of using a Mycobacterium tuberculosis coding sequence to facilitate stable and high yield expression of the heterologous proteins
US6316205B1 (en) 2000-01-28 2001-11-13 Genelabs Diagnostics Pte Ltd. Assay devices and methods of analyte detection
WO2001062893A2 (en) 2000-02-25 2001-08-30 Corixa Corporation Compounds and methods for diagnosis and immunotherapy of tuberculosis
PT2133100E (pt) 2000-06-20 2012-01-11 Corixa Corp Antigénio mtb32a de mycobacterium tuberculosis com um local activo inactivado e suas proteínas de fusão
AU2003213118A1 (en) 2002-02-15 2003-09-09 Corixa Corporation Fusion proteins of mycobacterium tuberculosis
US20040072262A1 (en) 2002-10-11 2004-04-15 Montero-Julian Felix A. Methods and systems for detecting MHC class I binding peptides
US8715679B2 (en) 2004-02-09 2014-05-06 The Arizona Board Of Regents On Behalf Of The University Of Arizona Pili from Mycobacterium tuberculosis
EP2226332A1 (en) * 2004-06-17 2010-09-08 Beckman Coulter, Inc. Mycobacterium tuberculosis epitopes and methods of use thereof
BRPI0518933A2 (pt) 2004-11-16 2008-12-16 Crucell Holland B V E Aeras Gl adenovÍrus recombinante defeituoso de replicaÇço, vetor de polinucleotÍdeo recombinante, vacina multivalente da tuberculose, e, uso do antÍgeno tb10.4 de mycobacterium
PT2426141E (pt) 2005-04-29 2014-11-25 Glaxosmithkline Biolog Sa Método para prevenção ou tratamento de uma infecção por m. tuberculosis
LT2528621T (lt) 2010-01-27 2016-12-12 Glaxosmithkline Biologicals S.A. Modifikuoti tuberkuliozės antigenai
SG190937A1 (en) 2010-12-14 2013-07-31 Glaxosmithkline Biolog Sa Mycobacterium antigenic composition
WO2013119763A1 (en) 2012-02-07 2013-08-15 Intuitive Biosciences, Inc. Mycobacterium tuberculosis specific peptides for detection of infection or immunization in non-human primates
EP3210015A1 (en) 2014-10-23 2017-08-30 Qiagen Sciences, LLC Peptide composition and uses thereof
CN106008685A (zh) * 2016-05-18 2016-10-12 首都医科大学附属北京胸科医院 Trxc抗体识别的抗原多肽及其用途
WO2018068064A2 (en) * 2016-09-22 2018-04-12 Nguyen Hiep Hoa T Mycobacterium tuberculosis proteins in diagnostic assays and devices for tuberculosis detection and diagnosis
ES2933132T3 (es) 2017-05-05 2023-02-01 Biomerieux Sa Procedimiento para detectar una respuesta celular inmune
EP3399312A1 (fr) 2017-05-05 2018-11-07 Biomérieux Procédé de détection d'une réponse cellulaire immune
WO2021018919A1 (en) 2019-07-30 2021-02-04 Dna Script Template-free enzymatic synthesis of polynucleotides using poly(a) and poly(u) polymerases
CN111269856B (zh) * 2020-02-19 2021-11-30 首都医科大学附属北京胸科医院 一种分离和/或富集结核分枝杆菌的方法
CN116601294A (zh) * 2020-07-17 2023-08-15 波士顿大学董事会 病毒检测系统及其用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4751180A (en) 1985-03-28 1988-06-14 Chiron Corporation Expression using fused genes providing for protein product
US4935233A (en) 1985-12-02 1990-06-19 G. D. Searle And Company Covalently linked polypeptide cell modulators
EP0419355B1 (en) * 1989-09-19 2000-02-09 N.V. Innogenetics S.A. Recombinant polypeptides and peptides, nucleic acids coding for the same and use of these polypeptides and peptides in the diagnostic of tuberculosis
FR2677365B1 (fr) * 1991-06-07 1995-08-04 Pasteur Institut Proteines de mycobacterium et applications.
US5330754A (en) * 1992-06-29 1994-07-19 Archana Kapoor Membrane-associated immunogens of mycobacteria
US5359681A (en) 1993-01-11 1994-10-25 University Of Washington Fiber optic sensor and methods and apparatus relating thereto
DK79793D0 (da) * 1993-07-02 1993-07-02 Statens Seruminstitut Diagnostic test
DK79893D0 (da) * 1993-07-02 1993-07-02 Statens Seruminstitut New vaccine

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009084481A1 (ja) * 2007-12-28 2009-07-09 Bl Co., Ltd. 結核菌群の免疫検出法

Also Published As

Publication number Publication date
EP2154248B1 (en) 2011-10-26
CY2618B2 (enExample) 2012-10-24
ATE324445T1 (de) 2006-05-15
CN1154730C (zh) 2004-06-23
AU7158796A (en) 1997-03-27
EP0850305A2 (en) 1998-07-01
EP0850305B1 (en) 2006-04-26
CN1200146A (zh) 1998-11-25
EP2154248A1 (en) 2010-02-17
PT2154248E (pt) 2012-01-16
CA2230927A1 (en) 1997-03-13
DE69636075D1 (de) 2006-06-01
WO1997009429A2 (en) 1997-03-13
WO1997009429A3 (en) 1997-07-17
ES2378051T3 (es) 2012-04-04
CN1554664A (zh) 2004-12-15
ATE530671T1 (de) 2011-11-15
DK2154248T3 (da) 2012-01-30
MX9801687A (es) 1998-11-29

Similar Documents

Publication Publication Date Title
US7122196B2 (en) Compounds and methods for diagnosis of tuberculosis
EP0850305B1 (en) Compounds and methods for diagnosis of tuberculosis
JP2001500383A (ja) 結核診断用の化合物および方法
US6607728B2 (en) Compounds and methods for the diagnosis and treatment of ehrlichia infection
US5618533A (en) Flagellin-based polypeptides for the diagnosis of lyme disease
CA2290754A1 (en) Compounds for diagnosis of tuberculosis and methods for their use
JP2001517069A (ja) 結核の免疫治療および診断のための化合物および方法
US6231869B1 (en) Compounds and methods for the diagnosis and treatment of ehrlichia infection
KR20000049101A (ko) 결핵을 진단하고, 결핵에 대한 면역요법용 화합물 및 방법
JP2002503683A (ja) 結核の免疫療法および診断のための化合物および方法
JPH11502923A (ja) Ｔ．ｃｒｕｚｉ感染検出用の化合物および方法
US6277381B1 (en) Compounds and methods for the diagnosis and treatment of Ehrlichia infection
US6166177A (en) Compounds and methods for the treatment and diagnosis of chlamydial infection
US20030170260A1 (en) Antigenic peptide fragments of vapa protein, and uses thereof
EP0834567A2 (en) Compounds and methods for the diagnosis and treatment of Babesia microti infection
EP1282711A2 (en) COMPOUNDS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF i EHRLICHIA INFECTION /i
EP0879244A1 (en) Mycoplasma recombinant polypeptide vaccines
EP1169455A1 (en) Compounds and methods for the diagnosis and treatment of babesia microti infection
WO1999029869A1 (en) Compounds and methods for the diagnosis and treatment of b. microti infection
EP1712629A2 (en) Compounds and methods for diagnosis of tuberculosis
AU2001252038B2 (en) Antigenic peptide fragments of vapa protein, and uses thereof
HK1099337A (en) Compounds and methods for diagnosis of tuberculosis
HK1138040A (en) Compounds and methods for diagnosis of tuberculosis
KR20000049100A (ko) 결핵을 진단하는 화합물 및 방법
AU2001252038A1 (en) Antigenic peptide fragments of VapA protein, and uses thereof

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20070130

A313 Final decision of rejection without a dissenting response from the applicant

Free format text: JAPANESE INTERMEDIATE CODE: A313

Effective date: 20070620

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20070731